MX2011008323A - Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. - Google Patents

Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.

Info

Publication number
MX2011008323A
MX2011008323A MX2011008323A MX2011008323A MX2011008323A MX 2011008323 A MX2011008323 A MX 2011008323A MX 2011008323 A MX2011008323 A MX 2011008323A MX 2011008323 A MX2011008323 A MX 2011008323A MX 2011008323 A MX2011008323 A MX 2011008323A
Authority
MX
Mexico
Prior art keywords
renal
prognosis
diagnosis
compositions
methods
Prior art date
Application number
MX2011008323A
Other languages
English (en)
Spanish (es)
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of MX2011008323A publication Critical patent/MX2011008323A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
MX2011008323A 2009-02-06 2010-02-05 Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. MX2011008323A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US15039309P 2009-02-06 2009-02-06
US15037409P 2009-02-06 2009-02-06
US15037209P 2009-02-06 2009-02-06
US16240209P 2009-03-23 2009-03-23
US16239609P 2009-03-23 2009-03-23
US16633309P 2009-04-03 2009-04-03
PCT/US2010/023292 WO2010091231A1 (en) 2009-02-06 2010-02-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
MX2011008323A true MX2011008323A (es) 2011-09-21

Family

ID=42542388

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011008323A MX2011008323A (es) 2009-02-06 2010-02-05 Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.

Country Status (11)

Country Link
US (1) US20160123996A1 (enExample)
EP (1) EP2393937A4 (enExample)
JP (3) JP2012517592A (enExample)
CN (3) CN102369293B (enExample)
AU (1) AU2010210535B2 (enExample)
BR (1) BRPI1007917A2 (enExample)
CA (1) CA2751424A1 (enExample)
HK (1) HK1200218A1 (enExample)
MX (1) MX2011008323A (enExample)
NZ (1) NZ630621A (enExample)
WO (1) WO2010091231A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010025434A1 (en) 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2766228A1 (en) * 2009-07-02 2011-01-06 Mosaiques Diagnostics And Therapeutics Ag Process and markers for the diagnosis of acute renal failure
BR112013006631A2 (pt) * 2010-09-24 2017-10-24 Astute Medical Inc métodos e composições para a avaliação de lesão renal utilizando ácido hialurônico
WO2014028339A1 (en) * 2012-08-11 2014-02-20 Astute Medical, Inc. Evaluating renal injury using hyaluronic acid
CN105209914B (zh) * 2013-01-29 2017-04-19 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN110007084B (zh) * 2013-12-03 2022-11-18 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
CL2015003047A1 (es) 2015-10-15 2016-06-17 Univ Chile Método ex vivo para detectar precozmente injuria renal aguda en pacientes críticos, que comprende la mediciom en una muestra de tres proteinas como biomarcadores, factor de crecimiento fibroblástico 23, klotho y eritropoyetina
CN105466984B (zh) * 2016-01-14 2018-12-28 郑以山 用于肾脏非显性损伤的预警装置及其使用方法
EP3410119B1 (en) * 2016-01-29 2021-03-17 Karydo Therapeutix, Inc. Renal function evaluating device, device for predicting onset of kidney disease complications, and phosphorous ingestion amount estimating device
CN106845140A (zh) * 2017-03-01 2017-06-13 重庆工商大学 一种基于尿比重和尿量监测的肾衰竭预警方法及系统
US20200182885A1 (en) * 2017-05-30 2020-06-11 Sphingotec Gmbh A method for diagnosing or monitoring kidney function or diagnosing kidney dysfuntion
CN109897108B (zh) * 2019-03-11 2021-04-02 上海恒赛生物科技有限公司 抗人内皮蛋白c受体的羊驼单域抗体及应用
EP3881862A1 (de) * 2020-03-18 2021-09-22 Pharis Biotec GmbH Polypeptid zur therapie von glomerulären nierenerkrankungen und analyse des verlaufes und prognose der abhängigen syndrome

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3569577B2 (ja) * 1995-09-04 2004-09-22 株式会社いかがく 腎・尿路系疾患の鑑別診断用キット
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
US6228360B1 (en) * 1998-08-19 2001-05-08 Ajinomoto Co., Inc. Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
JP2003030100A (ja) * 2001-07-12 2003-01-31 Fuji Xerox Co Ltd インターネット情報提供システムおよびインターネット情報提供方法
ES2268961B1 (es) * 2005-03-17 2008-03-16 Proyecto De Biomedicina Cima, S.L. Nueva proteina epcr soluble de origen no proteolitico y su uso.
CA2614935A1 (en) * 2005-07-21 2007-02-01 The Johns Hopkins University Methods of detecting and treating acute kidney injury
TW200726845A (en) * 2006-01-02 2007-07-16 Nat Defense Medical Ct Biomarker molecular of renal illness and detecting method for the same
US7662578B2 (en) * 2006-04-21 2010-02-16 Children's Hospital Medical Center Method and kit for the early detection of impaired renal status
US20080038269A1 (en) * 2006-05-25 2008-02-14 Mount Sinai Hospital Methods for detecting and treating kidney disease
GB0617429D0 (en) * 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
US7842472B2 (en) * 2006-11-14 2010-11-30 Alere International Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
EP2160478B1 (en) * 2007-06-06 2014-08-27 Siemens Healthcare Diagnostics Inc. Predictive diagnostics for kidney disease

Also Published As

Publication number Publication date
JP2016194526A (ja) 2016-11-17
CN106546752A (zh) 2017-03-29
EP2393937A1 (en) 2011-12-14
HK1162617A1 (en) 2012-08-31
JP2012517592A (ja) 2012-08-02
HK1200218A1 (en) 2015-07-31
WO2010091231A1 (en) 2010-08-12
CN104111336B (zh) 2017-01-18
BRPI1007917A2 (pt) 2019-09-24
JP2015096870A (ja) 2015-05-21
US20160123996A1 (en) 2016-05-05
CA2751424A1 (en) 2010-08-12
AU2010210535B2 (en) 2015-12-10
EP2393937A4 (en) 2012-08-08
AU2010210535A1 (en) 2011-09-15
CN104111336A (zh) 2014-10-22
CN102369293A (zh) 2012-03-07
CN102369293B (zh) 2014-05-28
NZ630621A (en) 2016-03-31

Similar Documents

Publication Publication Date Title
EP2539712A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2813848A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2767833A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2585827A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
MX346096B (es) Métodos y composiciones para diagnóstico y pronóstico de lesión renal e insuficiencia renal.
MX341926B (es) Metodos y composiciones para la diagnosis y prognosis de daño renal y falla renal.
NZ625423A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
MX2012001559A (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
EP2582847A4 (en) METHOD AND MATERIALS FOR EVALUATING THE LOSS OF HETEROZYGOTY
NZ592488A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
PH12012500850A1 (en) Methods for diagnosing irritable bowel syndrome
WO2011035012A3 (en) Methods and compositions for diagnosing heart failure
WO2008061149A3 (en) Methods and compositions for diagnosis and prognosis of renal artery stenosis
NZ624609A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2009101059A3 (en) Methods of using cadherin 11 (cdh11) antagonists
WO2016064877A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201490105A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
WO2012094658A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2012003168A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal.
NZ630621A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2009010751A (es) Composiciones y metodos de deteccion.
WO2012085574A3 (en) Detection of acute myeloid leukaemia
WO2008110593A3 (de) Verfahren und marker zur diagnose von nierenerkrankungen

Legal Events

Date Code Title Description
FG Grant or registration